This report presents data from the National Enhanced Legionnaires' Disease Surveillance Scheme (NELSS), covering all confirmed cases of Legionellosis among residents of England and Wales with symptom onset between January 1 and December 31, 2025. The report's purpose is to analyse confirmed cases, which meet specific clinical and laboratory criteria, and compare findings against data from previous years. Data is drawn from national surveillance scheme reporting forms and population estimates are based on the ONS census. The report will provide an epidemiological summary, analyse overall trends…
This register contains all websites that are authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) to sell medicines online, in Northern Ireland.
Interim update to the guidance on the most effective methods of prevention and control of Clostridioides difficile infection. This guidance is currently under review.
Mandatory surveillance of healthcare-associated infections (HCAI), which include methicillin-resistant Staphylococcus aureus (MRSA), Methicillin-sensitive Staphylococcus aureus (MSSA), Gram-negative bacteraemia such as Escherichia coli (E. coli), Klebsiella and Pseudomonas aeruginosa (P. aeruginosa) and Clostridioides difficile (C. difficile, or CDI): May 2025 to May 2026.
Methodology behind the estimated figures for financial and clinical hours saved, and A&E and hospital visits lessened, from introducing the single patient record.
Updated technical guidelines by the European Centre for Disease Prevention and Control (ECDC) will help prevent the transmission of hepatitis B virus (HBV) and hepatitis C virus (HCV) through substances of human origin, including donated blood, stem cells, reproductive cells, and tissue, and establish a single, EU-wide standard for patient safety during medical procedures.